共 50 条
- [22] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
- [23] IMPROVED SURVIVAL TIMES IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU - M-2 PROTOCOL AMERICAN JOURNAL OF MEDICINE, 1977, 63 (06): : 897 - 903
- [24] VINCRISTINE-BCNU-ADRIAMYCIN-PREDNISONE COMBINATION FOR TREATMENT OF MELPHALAN-RESISTANT AND CYTOXAN-RESISTANT MULTIPLE-MYELOMA PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 343 - 343
- [27] MULTIPLE-MYELOMA RESISTANT TO MELPHALAN - TREATMENT WITH DOXORUBICIN, CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND PREDNISONE CANCER TREATMENT REPORTS, 1982, 66 (03): : 451 - 456
- [29] TREATMENT OF ALKYLATING RESISTANT MULTIPLE-MYELOMA WITH VINCRISTINE, BCNU, DOXORUBICIN AND PREDNISONE (VBAP) EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (10): : 1193 - 1197